Cleveland Clinic researchers to use BioSig tech to gain insights into ablation

BioSig Technologies this week announced it signed a master research agreement with the Cleveland Clinic to explore expanded indications for digital signal processing in arrhythmia care.

The Westport, Connecticut-based company will sponsor a research agreement with the Cleveland Clinic Foundation to investigate expanded clinical applications for the intracardiac signals that are acquired by its Pure EP system. Through the agreement, Cleveland Clinic will conduct physician-initiated scientific research investigating Pure EP potential to address common limitations of signal processing and signal use expansion during electrophysiology ablation procedures.

Cleveland Clinic was selected as the research partner based on its world-class physician faculty, research competency and mutual interest in using digital signal processing technology to advance the field of cardiac electrophysiology.

“As a non-profit, research, education, and healthcare institution, Clevel…

Read more
  • 0

BioSig, Mayo Clinic announce AI development partnership

The Pure EP system [Image courtesy of BioSig Technologies]

BioSig Technologies (NSDQ:BSGM) will work with the Mayo Foundation for Medical Education and Research to develop next-gen, AI-powered software for its  Pure EP system, which is meant to take electrophysiology to the next level.

The Mayo Clinic has already been an important investor and development partner for the Westport, Conn.–based company. BioSig signed a 10-year collaboration agreement with Mayo Clinic in March 2017, signing three new patent and know-how license agreements with the Mayo foundation in November 2019.

The new R&D collaboration, announced yesterday, will find ways to use artificial intelligence and machine learning to boost the clinical value of Pure EP and its proprietary hardware and software with advanced signal processing capabilities. Dr. Samuel J. Asirvatham, Mayo Clinic’s vice chair of innovation and Electrophysiology…

Read more
  • 0